CD8A and neoplasm: To evaluate correlations between the advancement stage and the immunogenicity status of tumors, the number of CD4+, CD8+, CD25+, FoxP3+ and CD20+ TILs in invasive tumors was analyzed in relation to the phase of tumor development, as indicated by pT stage.